Evers, Stefan
Dell’Agnello, Grazia http://orcid.org/0000-0002-5482-6065
Novick, Diego
Gonderten, H. Saygin
Panni, Tommaso
Pascual, Julio
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 6 December 2023
Accepted: 22 February 2024
First Online: 16 April 2024
Declarations
:
: Stefan Evers has received honoraria for lectures and consulting fees from Eli Lilly, Lundbeck, Novartis, Perfood, Rehaler, and Teva (in the last 3 years). Grazia Dell’Agnello, Diego Novick, Saygin Gonderten, and Tommaso Panni are employees and minor shareholders of Eli Lilly and Company. Julio Pascual has participated in Symposia and Advisory Boards of Allergan, Amgen-Novartis, Biohaven, Teva, and Lilly.
: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. Ethical review board approval for the study was granted by the Marqués de Valdecilla University Hospital (Spain) and participants were required to provide informed consent prior to commencing the study by selecting “I agree to participate” on the online form. All survey respondents provided informed consent and all data were anonymized before analysis.